"MIT's Implantable Oxygen Device: A Game-Changer for Diabetes Care"

MIT engineers have developed an implantable device that could revolutionize the treatment of Type 1 diabetes by replacing daily insulin injections. The device contains insulin-producing cells and an onboard oxygen factory that generates oxygen by splitting water vapor in the body. In tests on diabetic mice, the device successfully maintained stable glucose levels for over a month. The researchers aim to create a larger version of the device for human testing. This technology could potentially be adapted to treat other diseases requiring repeated delivery of therapeutic proteins.